Second Sight Medical Products Inc (EYES)

[zitry]

I expect near term financials to be lackluster. In spite of this, I believe EYES share price has the potential for substantial gains in the near term. It hinges on the success of ORION. EYES is the leader and the market is so very well defined. Each potential customer can literally be touched by EYES. The world wide press coverage (free advertising) continues to gain momentum. The most that can be lost is $1.60/share and the upside is nearly unlimited. ORION requires invasive surgery, so what bothers me the most is the time frame for FDA approvals. This could stretch out until adverse reactions can be determined.